Search results
Pharma lobbying up in 2024
Politico· 6 days agoThe FDA approved Novo Nordisk’s weight-loss drug Wegovy earlier this year to reduce the risk of major cardiovascular deaths in people with heart disease. CMS followed up by ...
About 3.6 million Medicare beneficiaries could be eligible for Wegovy coverage, study shows
WHTC 1450 Holland· 6 days ago(Reuters) - About 3.6 million overweight or obese patients with heart conditions insured under the...
FDA approval of Wegovy could give millions on Medicare access to weight-loss drug
PhillyVoice.com· 6 days agoWith this new approval, and the drug's possible dual use, millions of people on Medicare may be able...
Wave of Amicus Briefs Back Drug Price Plan at Trial Court Stage
Bloomberg Law· 4 days agoThe Biden administration’s efforts to fend off legal challenges from the pharmaceutical industry battling Medicare drug price negotiations has drawn reinforcements ...
New rules mean 3.6 million Americans could get Wegovy via Medicare, costing billions
Medical Xpress· 6 days agoThe FDA's ruling potentially allows Wegovy prescription coverage for more than a quarter of 13.7...
Analysts revisit Humana stock price targets amid Medicare Advantage hit
TheStreet via Yahoo Finance· 4 days agoUnder the act, private health plans approved by Medicare became known as Medicare Advantage Plans....
Wegovy could soon treat millions of Medicare patients
Quartz· 6 days agoMillions of Americans could now be eligible for Medicare to cover their prescriptions of the popular...
Brand New Day Medicare Advantage 2024 Review - NerdWallet
Nerdwallet· 5 days agoStar ratings are determined by the Centers for Medicare & Medicaid Services (CMS). Brand New Day...
Analysts revisit Humana stock price targets amid Medicare Advantage hit
TheStreet.com· 4 days agoHere's what could happen next to Humana shares. When then-President George W. Bush signed the Medicare Prescription Drug, Improvement, and Modernization ...
CMS Publishes Final Rules Implementing Part C and Part D Program Changes | JD Supra
JD Supra· 6 days ago...On April 23, 2024, the Centers for Medicare & Medicaid Services (CMS) published final rules setting forth Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Program for Contract Year 2024--Remaining Provisions and Contract Year 2025 Policy and Technical Changes to the ...